Dipyaman Ganguly | Academic Influence

Dipyaman Ganguly's AcademicInfluence.com Rankings

Dipyaman Ganguly

Computer Science

#12671

World Rank

#13563

Historical Rank

Machine Learning

#5841

World Rank

#5928

Historical Rank

Artificial Intelligence

#6296

World Rank

#6404

Historical Rank

Database

#9781

World Rank

#10355

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Dipyaman Ganguly's Degrees

Masters Computer Science Stanford University
Bachelors Computer Science University of California, Berkeley

Similar Degrees You Can Earn

Why Is Dipyaman Ganguly Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Dipyaman Ganguly is an Indian physician-scientist immunologist and cell biologist, currently a Principal Scientist and Swarnajayanthi Fellow at the CSIR-Indian Institute of Chemical Biology . He heads the Dendritic Cell Laboratory of IICB, popularly known as the Ganguly Lab, where he hosts several researchers involved in research on regulation of innate Immunity and pathogenesis of inflammatory disorders. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Medical Sciences in 2022.

(See a Problem?)

Dipyaman Ganguly's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA–Peptide Complexes in Systemic Lupus Erythematosus (2011) (1105)
Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8 (2009) (657)
The role of dendritic cells in autoimmunity (2013) (402)
Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past (2020) (286)
Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus (2014) (186)
TH17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26 (2015) (172)
Cationic antimicrobial peptides in psoriatic skin cooperate to break innate tolerance to self‐DNA (2015) (124)
Generation of IL-23 Producing Dendritic Cells (DCs) by Airborne Fungi Regulates Fungal Pathogenicity via the Induction of TH-17 Responses (2010) (116)
Cutting Edge: Piezo1 Mechanosensors Optimize Human T Cell Activation (2018) (77)
Adipose Recruitment and Activation of Plasmacytoid Dendritic Cells Fuel Metaflammation (2016) (75)
Lactate Induces Pro-tumor Reprogramming in Intratumoral Plasmacytoid Dendritic Cells (2019) (58)
Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial (2020) (54)
Nucleic acid-containing amyloid fibrils potently induce type I interferon and stimulate systemic autoimmunity (2012) (53)
Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species‐dependent JNK and endothelial nitric oxide synthase activation and overrides imatinib resistance (2012) (46)
Suggestive evidence of association of C-159T functional polymorphism of the CD14 gene with atopic asthma in northern and northwestern Indian populations (2004) (41)
Nature and dimensions of the systemic hyper-inflammation and its attenuation by convalescent plasma in severe COVID-19. (2021) (41)
N-acetyl cysteine enhances imatinib-induced apoptosis of Bcr-Abl+ cells by endothelial nitric oxide synthase-mediated production of nitric oxide (2009) (38)
KLK5 induces shedding of DPP4 from circulatory Th17 cells in type 2 diabetes (2017) (36)
Do Type I Interferons Link Systemic Autoimmunities and Metabolic Syndrome in a Pathogenetic Continuum? (2018) (34)
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19 (2022) (27)
Leishmania donovani infection of human myeloid dendritic cells leads to a Th1 response in CD4+ T cells from healthy donors and patients with kala-azar. (2006) (25)
Granulocyte–macrophage colony‐stimulating factor drives monocytes to CD14low CD83+ DCSIGN– interleukin‐10‐producing myeloid cells with differential effects on T‐cell subsets (2007) (22)
Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma (2022) (22)
Insights from a Pan India Sero-Epidemiological survey (Phenome-India Cohort) for SARS-CoV2 (2021) (20)
Endocannabinoids in immune regulation and immunopathologies (2021) (15)
Mechanical Cues for T Cell Activation: Role of Piezo1 Mechanosensors. (2019) (12)
Cutting Edge: Dysregulated Endocannabinoid-Rheostat for Plasmacytoid Dendritic Cell Activation in a Systemic Lupus Endophenotype (2019) (10)
Structural Evolution and Translational Potential for Agonists and Antagonists of Endosomal Toll-like Receptors. (2021) (9)
Nature and dimensions of the cytokine storm and its attenuation by convalescent plasma in severe COVID-19 (2020) (9)
Self-Nucleic Acid Sensing: A Novel Crucial Pathway Involved in Obesity-Mediated Metaflammation and Metabolic Syndrome (2021) (8)
The RNase MCPIP3 promotes skin inflammation by orchestrating myeloid cytokine response (2021) (8)
Activity-guided development of potent and selective toll-like receptor 9 antagonists. (2018) (7)
A Chemical switch for transforming a purine agonist for Toll-like receptor 7 to a clinically relevant antagonist. (2020) (6)
Nature and dimensions of the systemic hyper-inflammation and its attenuation by convalescent plasma in severe COVID-19 (2021) (6)
Design and development of benzoxazole derivatives with toll-like receptor 9 antagonism. (2017) (6)
Systematic Optimization of Potent and Orally Bioavailable Purine Scaffold as a Dual Inhibitor of Toll-Like Receptors 7 and 9. (2021) (5)
A machine learning-based approach to determine infection status in recipients of BBV152 (Covaxin) whole-virion inactivated SARS-CoV-2 vaccine for serological surveys (2021) (5)
Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19 (2021) (5)
Dendritic cells and antigen trapping technology--a revolution in vaccine/immunotherapy strategy. (2007) (4)
SYBR green one-step qRT-PCR for the detection of SARS-CoV-2 RNA in saliva (2020) (3)
Synthesis and characterization of new potent TLR7 antagonists based on analysis of the binding mode using biomolecular simulations. (2020) (3)
A prospective study on COVID‐19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centre (2021) (2)
Post Exercise Desaturation Can Help Identifying Treatment Responders of COPD Pulmonary Hypertension in Real World: An Appraisal (2018) (2)
TLR9 Polymorphisms Might Contribute to the Ethnicity Bias for EBV-Infected Nasopharyngeal Carcinoma (2020) (1)
Role of Ca2+ in toll-like receptor 9 activation in human plasmacytoid dendritic cells. (2019) (1)
Integration of Ligand-Based and Structure-Based Methods for the Design of Small-Molecule TLR7 Antagonists (2022) (1)
Development, Optimization, and In Vivo Validation of New Imidazopyridine Chemotypes as Dual TLR7/TLR9 Antagonists through Activity-Directed Sequential Incorporation of Relevant Structural Subunits. (2022) (1)
Plasmacytoid Dendritic Cells (2022) (0)
Immune recognition of self nucleic acids driven by endogenous antimicrobial peptides: role in autoimmunity (2010) (0)
Immunobiology of Granulocyte Macrophage Colony Stimulating Factor Driven Human Myeloid Cells (2006) (0)
Lande Peptide Complexes in Systemic Lupus Erythematosus − Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA (2011) (0)
An Observational Study showing Dipeptidyl Peptidase-4 (DPP-4) Activity and Gene Expression Variation in Chronic Liver Disease (CLD) Patients from a Tertiary Care Hospital of Eastern India (2022) (0)
Lipid-Induced Insulin Resistance: Molecular Mechanisms and Clinical Implications (2018) (0)
The ‘Public’ and the ‘Outreach’: Public Outreach of Science in India (2018) (0)
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19 (2022) (0)
Pathogenetic cross-talk between plasmacytoid dendritic cells and B regulatory cells in systemic lupus erythematosus: Influence of therapeutic regime (2014) (0)
Title : T ( H ) 17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26 (0)
Optimize Human T Cell Activation Cutting Edge : Piezo 1 (2018) (0)
Psoriasis and Diabetes: An Unholy Alliance (2017) (0)
Piezo1 mechanosensing regulates integrin-dependent chemotactic migration in human T cells (2022) (0)
Plasma gradient of soluble urokinase-type 1 plasminogen activator receptor is linked to 2 pathogenic plasma proteome and immune 3 transcriptome and stratifies outcomes in severe 4 COVID-19 5 6 (2021) (0)
Gut dysbiosis and metabolic diseases. (2022) (0)
CHAPTER 13. Small Molecule Modulators of Endo-lysosomal Toll-like Receptors (2020) (0)
Deficient Phagocytosis in Circulating Monocytes from Patients with COVID-19-Associated Mucormycosis (2023) (0)
Inactivated tumor infiltrating CD8+ T cells in primary and metastatic osteosarcoma (2007) (0)
Circulating Interleukin-8 Dynamics Parallels Disease Course and Is Linked to Clinical Outcomes in Severe COVID-19 (2023) (0)
Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19 (2022) (0)
Lung epithelial response to SARS-CoV2 and diabetes (2020) (0)
Mitigating hERG Liability of Toll-Like Receptor 9 and 7 Antagonists through Structure-Based Design. (2023) (0)
Protective role of ACE inhibitors and ARBs in hypertensive patients suffering from COVID-19 (2020) (0)
Multi-omics studies in interpreting the evolving standard model for immune functions. (2023) (0)

This paper list is powered by the following services:

Other Resources About Dipyaman Ganguly

en.wikipedia.org

What Schools Are Affiliated With Dipyaman Ganguly?

Dipyaman Ganguly is affiliated with the following schools: